Clinical characteristics and pharmacokinetics of PAXLOVID in COVID-19 patients with hematological tumor

Med Rev (2021). 2024 Mar 4;4(2):169-171. doi: 10.1515/mr-2023-0068. eCollection 2024 Apr.

Authors

Wei Liu^{1

2

3

4}, Ping Yang^{1

2

4

3}, Ping Yang⁵, Li Yang^{1

2

4

3}, Hongmei Jing⁵, Libo Zhao^{1

2

4

3}, Rongsheng Zhao^{1

2

4

3}

Affiliations

¹ Department of Pharmacy, Peking University Third Hospital, Beijing, China.
² Therapeutic Drug Monitoring and Clinical Toxicology Center of Peking University, Beijing, China.
³ NMPA Key Laboratory for Research and Evaluation of Generic Drugs, Beijing, China.
⁴ Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
⁵ Department of Hematology, Peking University Third Hospital, Beijing, China.

No abstract available